← Back to catalogue

IFA L. pneumophila Group 1-6 Test System

FDA UDI

by Zeus Scientific, Inc.

Identity

Trade Name
IFA L. pneumophila Group 1-6 Test System FDA UDI
Generic Name
Legionella pneumophila total antibody IVD, kit, fluorescent immunoassay FDA UDI
Device Name
The ZEUS IFA Legionella pneumophila (Group 1 - 6) Test System is an indirect fluorescent antibody (IFA) assay designed for the detection of L. pneumophila antibodies in human serum, and is for In Vitro diagnostic use. FDA UDI
Model / Reference
FA15001 FDA UDI
Description
The ZEUS IFA Legionella pneumophila (Group 1 - 6) Test System is an indirect fluorescent antibody (IFA) assay designed for the detection of L. pneumophila antibodies in human serum, and is for In Vitro diagnostic use. FDA UDI

Identifiers

Catalog Number
FA15001 FDA UDI
Primary DI / UDI-DI
00845533001670 FDA UDI
GMDN Term
Legionella pneumophila total antibody IVD, kit, fluorescent immunoassay FDA UDI

Classification

Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Legionella pneumophila total antibody IVD, kit, fluorescent immunoassay

IFA L. pneumophila Group 1-6 Test System by Zeus Scientific, Inc. — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Legionella pneumophila total antibody IVD, kit, fluorescent immunoassay.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 306f14d3-9e38-4709-859c-41fc39aa8696 35 fields · synced May 30, 2026